Recent developments in Campylobacter pathogenesis.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 14502003)

Published in Curr Opin Infect Dis on October 01, 2003


Stefan Bereswill1, Manfred Kist

Author Affiliations

1: Department of Microbiology and Hygiene, Institute of Medical Microbiology and Hygiene, University Hospital Freiburg, Germany.

Articles citing this

Novel murine infection models provide deep insights into the "ménage à trois" of Campylobacter jejuni, microbiota and host innate immunity. PLoS One (2011) 2.20

Genome sequence of a clinical isolate of Campylobacter jejuni from Thailand. Infect Immun (2007) 1.61

Development and application of an insertional system for gene delivery and expression in Campylobacter jejuni. Appl Environ Microbiol (2005) 1.44

Outer membrane vesicle-mediated release of cytolethal distending toxin (CDT) from Campylobacter jejuni. BMC Microbiol (2009) 1.19

What you eat is what you get: Novel Campylobacter models in the quadrangle relationship between nutrition, obesity, microbiota and susceptibility to infection. Eur J Microbiol Immunol (Bp) (2011) 1.15

Can microbiota transplantation abrogate murine colonization resistance against Campylobacter jejuni? Eur J Microbiol Immunol (Bp) (2013) 0.93

Molecular signatures (unique proteins and conserved indels) that are specific for the epsilon proteobacteria (Campylobacterales). BMC Genomics (2006) 0.90

Mortality following Campylobacter infection: a registry-based linkage study. BMC Infect Dis (2005) 0.89

FdhTU-modulated formate dehydrogenase expression and electron donor availability enhance recovery of Campylobacter jejuni following host cell infection. J Bacteriol (2012) 0.88

Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models. Eur J Microbiol Immunol (Bp) (2016) 0.88

Comparison of PCR binary typing (P-BIT), a new approach to epidemiological subtyping of Campylobacter jejuni, with serotyping, pulsed-field gel electrophoresis, and multilocus sequence typing methods. Appl Environ Microbiol (2009) 0.85

Effector prediction in host-pathogen interaction based on a Markov model of a ubiquitous EPIYA motif. BMC Genomics (2010) 0.81

Identification of immunogenic and virulence-associated Campylobacter jejuni proteins. Clin Vaccine Immunol (2011) 0.80

Characterization and localization of the Campylobacter jejuni transformation system proteins CtsE, CtsP, and CtsX. J Bacteriol (2014) 0.75

Articles by these authors

Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol (2006) 3.18

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut (2012) 2.49

Transcriptional profiling of Helicobacter pylori Fur- and iron-regulated gene expression. Microbiology (2005) 1.85

The Helicobacter pylori homologue of the ferric uptake regulator is involved in acid resistance. Infect Immun (2002) 1.65

Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PLoS One (2011) 1.45

Essential role of ferritin Pfr in Helicobacter pylori iron metabolism and gastric colonization. Infect Immun (2002) 1.43

Iron-responsive regulation of the Helicobacter pylori iron-cofactored superoxide dismutase SodB is mediated by Fur. J Bacteriol (2005) 1.40

NikR mediates nickel-responsive transcriptional induction of urease expression in Helicobacter pylori. Infect Immun (2002) 1.37

Differential regulation of amidase- and formamidase-mediated ammonia production by the Helicobacter pylori fur repressor. J Biol Chem (2002) 1.33

The novel Helicobacter pylori CznABC metal efflux pump is required for cadmium, zinc, and nickel resistance, urease modulation, and gastric colonization. Infect Immun (2006) 1.31

The role of the Ferric Uptake Regulator (Fur) in regulation of Helicobacter pylori iron uptake. Helicobacter (2002) 1.29

Helicobacter pylori multiplex serology. Helicobacter (2009) 1.29

Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol (2002) 1.22

The Helicobacter pylori CrdRS two-component regulation system (HP1364/HP1365) is required for copper-mediated induction of the copper resistance determinant CrdA. J Bacteriol (2005) 1.20

A novel system of cytoskeletal elements in the human pathogen Helicobacter pylori. PLoS Pathog (2009) 1.15

Magnesium uptake by CorA is essential for viability of the gastric pathogen Helicobacter pylori. Infect Immun (2002) 1.10

Helicobacter pylori and gastroduodenal ulcer disease. Dtsch Arztebl Int (2009) 1.07

Quinolone resistance in Helicobacter pylori isolates in Germany. Antimicrob Agents Chemother (2006) 1.07

Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany. J Antimicrob Chemother (2009) 0.97

Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol. Am J Cardiol (2004) 0.96

Identification of beta-subunit of bacterial RNA-polymerase--a non-species-specific bacterial protein--as target of antibodies in primary biliary cirrhosis. Dig Dis Sci (2003) 0.95

Pathogenesis of Helicobacter pylori infection. Helicobacter (2004) 0.93

Identification by RNA profiling and mutational analysis of the novel copper resistance determinants CrdA (HP1326), CrdB (HP1327), and CzcB (HP1328) in Helicobacter pylori. J Bacteriol (2002) 0.93

Rapid detection of point mutations in the gyrA gene of Helicobacter pylori conferring resistance to ciprofloxacin by a fluorescence resonance energy transfer-based real-time PCR approach. J Clin Microbiol (2004) 0.90

Novel plasmids for gene expression analysis and for genetic manipulation in the gastric pathogen Helicobacter pylori. FEMS Immunol Med Microbiol (2005) 0.87

Analysis of the rdxA gene in high-level metronidazole-resistant clinical isolates confirms a limited use of rdxA mutations as a marker for prediction of metronidazole resistance in Helicobacter pylori. FEMS Immunol Med Microbiol (2003) 0.87

Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori. Antimicrob Agents Chemother (2005) 0.85

Culture of a gastric non-Helicobacter pylori Helicobacter from the stomach of a 14-year-old girl. Helicobacter (2012) 0.85

Mutational analysis of the Helicobacter pylori carbonic anhydrases. FEMS Immunol Med Microbiol (2005) 0.85

Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin. BMC Res Notes (2012) 0.83

High secondary resistance to quinolones in German Helicobacter pylori clinical isolates. J Antimicrob Chemother (2013) 0.82

Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany. J Antimicrob Chemother (2007) 0.81

Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections. Int J Antimicrob Agents (2007) 0.80

Helicobacter pylori: primary antimicrobial resistance and first-line treatment strategies. Euro Surveill (2007) 0.78

Molecular microbiology and pathogenesis of Helicobacter and Campylobacter updated: a meeting report of the 11th conference on Campylobacter, Helicobacter and related organisms. Mol Microbiol (2002) 0.77

Isolation and eradication of a clinical isolate of Helicobacter pylori resistant to five antimicrobials in Germany. J Antimicrob Chemother (2010) 0.77

Effect of methanolic extract of Terminalia arjuna against Helicobacter pylori 26695 lipopolysaccharide-induced gastric ulcer in rats. J Pharm Pharmacol (2008) 0.77

[Differences of vacA alleles and cagA gene positivity of Helicobacter pylori strains isolated from two different countries: Turkey and Germany]. Mikrobiyol Bul (2012) 0.76

Travel-related Salmonella agama, Gabon. Emerg Infect Dis (2007) 0.75

Re: the impact of the stone age diet on gingival conditions in the absence of oral hygiene. Baumgartner S, Imfeld T, Schicht O, Rath C, Persson RE, Persson GR. (J Periodontol 2009;80:759-768.). J Periodontol (2010) 0.75

Nosocomial diarrhea caused by Salmonella derby infection in two patients on chemotherapy. Clin Microbiol Infect (1999) 0.75

Emergence of a Helicobacter pylori isolate with reduced susceptibility to tetracycline in Germany. J Antimicrob Chemother (2006) 0.75